Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	6.82	42.72	39.99
Graham Fair Price	-50.83	26.84	54.58
PEG	-108.66	-0.33	-0.16
Price/Book	-10.67	1.95	2.18
Price/Cash Flow	1624.44	-1032.49	59.87
Prices/Earnings	257.09	24.86	6.96
Price/Sales	-13.67	4.42	5.12
Price/FCF	1624.44	-1032.49	59.87
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-15.09	0.16	0.19
Operating Margin	17.05	0.08	0.07
ROA	-75.11	< 0.005	0.04
ROE	0.08	0.02	-74.98
ROIC	0.06	0.02	-69.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	91.54
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.20	0.17	-18.55
EPS QOQ	-0.44	-0.75	-71.14
FCF QOQ	-0.21	-1.05	-396.14
Revenue QOQ	-0.04	< 0.005	90.40
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	53.25	51.89	-2.56
Days Sales Outstanding (DSO)	70.81	75.66	6.85
Inventory Turnover	1.69	1.73	2.63
Debt/Capitalization	0.37	0.36	-2.02
Quick Ratio	1.13	0.85	-24.97
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	41.10	40.41	-1.69
Cash	5.61	3.42	-39.00
Capex	-0.72	-0.96	-33.27
Free Cash Flow	1.50	-0.08	-94.91
Revenue	17.51	17.81	1.72
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.72	1.29	-24.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.78	9.05	33.47
Naive Interpretation	Member

06 - Financial Health · Weak

Rating